Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Eclipsys Ends SMS Takeover Bid After Agreeing To Neoforma.com Merger

This article was originally published in The Gray Sheet

Executive Summary

Eclipsys effectively ended its takeover bid for rival healthcare IT provider Shared Medical Systems by withdrawing plans to propose a rebel slate of director candidates at SMS' annual shareholder meeting, following its decision to merge with online medical supply company Neoforma.com.

You may also be interested in...



Neoforma.com Salvages Novation Deal, Scraps Eclipsys/HealthVision Merger

Online medical equipment exchange Neoforma.com is handing over a hefty 45% of its equity to national health care alliances VHA, Inc. and University HealthSystems Consortium, part of the Novation group purchasing organization, under a revised agreement announced May 25.

Neoforma.com Salvages Novation Deal, Scraps Eclipsys/HealthVision Merger

Online medical equipment exchange Neoforma.com is handing over a hefty 45% of its equity to national health care alliances VHA, Inc. and University HealthSystems Consortium, part of the Novation group purchasing organization, under a revised agreement announced May 25.

Five Device Firms Hatch Industry-Controlled B2B Internet Exchange

A supplier-controlled medical device e-commerce exchange scheduled to debut in the U.S. in the third quarter and globally in 2001 will be open to all device manufacturers.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013185

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel